AB 1586 requires school resource officers (SROs) assigned to K–12 schoolsites in California to carry an opioid antagonist while on duty and to complete approved opioid overdose recognition and response training at least every two years beginning in the 2027–28 school year. The bill creates a limited civil and criminal immunity for SROs and their employers who, in good faith and without compensation, administer an opioid antagonist, unless their conduct rises to gross negligence or willful or wanton misconduct.
The statute also directs state agencies to issue implementation guidance, allows use of existing distribution programs and settlement funds to procure medications, and imposes annual operational reporting to POST with a mandated POST report to the Legislature due in 2031. For districts and law enforcement, the bill converts overdose response into an explicit school safety duty with training, supply, and data obligations to plan for and document on‑campus opioid interventions.
At a Glance
What It Does
AB 1586 requires every SRO to carry an FDA‑approved opioid antagonist while on duty at a schoolsite and complete POST‑ or DHCS‑approved overdose recognition and response training at least once every two years beginning 2027–28. It establishes limited immunity for good‑faith administration and creates reporting duties to POST for units received and uses.
Who It Affects
Local educational agencies, law enforcement agencies that assign SROs, and the SROs themselves are directly affected; public health and school safety planners must integrate overdose response into emergency protocols and procurement. POST and DHCS will provide training standards and guidance and receive annual data from SROs.
Why It Matters
The bill embeds naloxone carriage and training into school safety architecture — turning an emergency public health response into a routine obligation for SRO programs, changing budgeting, training calendars, evidence chain procedures, and data collection for opioid incidents on campus.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 1586 adds a focused public‑health duty to the SRO role: when an SRO is assigned to a schoolsite they must carry an opioid antagonist on their person while on duty, so that first response to suspected opioid overdoses on campus can happen immediately. The law defines key terms—local educational agency, opioid antagonist, schoolsite, and school resource officer—to make clear it applies to district, county office, and charter school assignments and to SROs who qualify as peace officers under state law.
The bill requires SROs to complete overdose recognition and response training approved by either the Commission on Peace Officer Standards and Training (POST) or the State Department of Health Care Services (DHCS), starting in the 2027–28 school year and at least once every two years. Agencies may fold that training into existing POST continuing professional requirements to reduce duplication.
The text cross‑references existing education code on volunteer administration of naloxone, so SROs may volunteer to administer an opioid antagonist to someone who appears to be overdosing.To limit liability concerns that could prevent lifesaving action, AB 1586 declares that when an SRO administers an opioid antagonist in good faith and without pay while assigned to a schoolsite, that act is treated as rendering emergency care; neither the officer nor their employer is civilly or criminally liable unless the conduct constitutes gross negligence or willful and wanton misconduct. The bill also directs DHCS, the Department of Education, and POST to provide implementation guidance on low‑ or no‑cost sources of opioid antagonists and how to integrate overdose response into school safety planning.Operationally, the bill requires SROs to report annually to POST the number of opioid antagonist units received, the number of administrations at schoolsites, and the number of times an officer needed one but did not have it available.
POST must compile those submissions and, in cooperation with the State Department of Public Health as needed, deliver a report to the Legislature by January 1, 2031; that reporting mandate lapses in 2035. Finally, the statute lists potential funding and procurement avenues—state naloxone distribution, opioid settlement funds, federal grants, and donations—rather than creating a dedicated appropriation.
The Five Things You Need to Know
The bill requires SROs to carry an FDA‑approved opioid antagonist on their person while on duty at a schoolsite.
Training: SROs must complete POST‑ or DHCS‑approved opioid overdose recognition and response training upon assignment and at least every two years, beginning in the 2027–28 school year.
Immunity: SROs and their employers receive civil and criminal immunity for good‑faith, uncompensated administration of an opioid antagonist unless the act constitutes gross negligence or willful or wanton misconduct.
Reporting: Each SRO must annually report to POST the units of opioid antagonist received, the number of administrations at schoolsites, and instances when an antagonist was needed but unavailable.
POST must submit a report to the Legislature by January 1, 2031, using the collected data; that reporting requirement becomes inoperative on January 1, 2035.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions: who and what the law covers
Subdivision (a) sets narrow, operational definitions: ‘local educational agency’ covers school districts, county offices, and charter schools; ‘opioid antagonist’ is naloxone or any FDA‑approved opioid antidote; ‘school resource officer’ is a peace officer assigned to schools; and ‘schoolsite’ includes campuses and locations of school‑sponsored activities. These definitions pin the law to traditional SRO deployments and limit its reach to K–12 settings, avoiding ambiguity about whether other school staff or community responders are covered.
Carry requirement for SROs
This provision mandates that each SRO ‘carry on their person’ an opioid antagonist while on duty at a schoolsite. Requiring personal carriage (not merely availability in a kit) accelerates time to treatment but creates practical questions about inventory control, expiration tracking, and chain‑of‑custody if medication is used or seized. Districts must decide whether to supply SROs directly or reimburse officers for procurement.
Training obligations and integration with POST standards
The bill requires initial and biennial overdose recognition and response training approved by POST or DHCS, starting in 2027–28. It explicitly allows the training to satisfy existing requirements under Section 49414.3 and to be integrated into POST continuing professional training. Practically, that creates a single certification path for SROs but also places on POST and DHCS the job of approving curricula and determining minimum competencies, including whether hands‑on administration practice or scenario training is required.
Limited civil and criminal immunity for administration
Subdivision (c) treats naloxone administration by SROs as rendering emergency care and shields officers and their employers from civil suits and criminal prosecution absent gross negligence or willful misconduct. This reduces legal friction that might deter intervention, but the statute’s liability standard will require courts to sort out borderline cases where poor technique or policy violations result in harm.
Guidance, reporting, and legislative reporting mandate
DHCS, the Department of Education, and POST must issue implementation guidance on accessing low‑ or no‑cost opioid antagonists and integrating overdose response into school safety plans. Officers must report yearly to POST on units received, uses, and shortages; POST compiles that data into a legislative report due Jan 1, 2031, with the reporting duty set to lapse in 2035. Those provisions create a data‑collection loop to inform future policymaking but also add administrative work for POST and local agencies.
Funding and procurement pathways
The statute does not appropriate funds; it lists potential sources—State Naloxone Distribution Project, opioid settlement funds, federal grants, and donations—to procure antagonists and support training. That approach reduces immediate fiscal impact on the state budget but shifts procurement and funding coordination to local agencies and creates uncertainty about sustained supply without a dedicated appropriation.
This bill is one of many.
Codify tracks hundreds of bills on Education across all five countries.
Explore Education in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Students and staff at K–12 campuses — they gain faster on‑site access to life‑saving opioid antagonists and trained first responders during school hours and school events.
- SROs who will administer care — the immunity and training reduce legal risk and clarify expectations for emergency response duties.
- Public health and school safety planners — the statute creates standardized data and training pathways that can improve response protocols and post‑incident analysis.
- Parents and community members — clearer procedures, guidance, and reporting may increase transparency about how schools handle on‑campus overdoses.
Who Bears the Cost
- Local educational agencies and districts — responsible for integrating new procedures into school safety plans, coordinating SRO training schedules, and ensuring access to antagonists (procurement, storage, expiration management).
- Law enforcement agencies that assign SROs — must supply medication, train officers, and track and report usage, potentially reallocating training budgets and resources.
- POST and DHCS — charged with approving training, issuing guidance, and receiving data; these agencies will incur administrative and analytic costs to implement standards and compile the legislatively required report.
- SRO employers (cities/counties) — may face increased operational liability exposure if policies are inadequate, and will need to manage inventory, recordkeeping, and replacement of used or expired medication.
Key Issues
The Core Tension
The bill resolves one urgent problem—delaying life‑saving naloxone by insisting on SRO carriage—but creates a trade‑off between rapid medical response and the institutional costs and role‑confusion that occur when schools assign more clinical responsibilities to law enforcement rather than to health staff; the question is whether faster access to antidote via SROs outweighs the operational and policy complications of making officers default medical responders.
AB 1586 stitches public‑health obligations onto a law‑enforcement role that was not originally designed for medical triage. Implementation will hinge on supply logistics (who buys and replaces expired doses), curriculum details (skills vs. awareness), and local decisions about whether SROs or other campus staff remain primary responders.
The bill avoids a direct appropriation and instead points to existing distribution channels and settlement funds; that saves the state money but leaves districts to secure reliable, ongoing supplies and to decide where costs will sit in local budgets.
The immunity language lowers the legal bar for intervention but leaves open difficult questions: what protocols will define ‘good faith,’ who documents the clinical decision to administer an antagonist, and how will investigations of adverse outcomes be handled where negligence is alleged but not obvious? The reporting requirement promises useful aggregate data but is limited to counts (received, used, needed) without requiring context such as demographics, outcome, or whether a student or staff member was involved, which constrains policy analysis and could understate racial, socioeconomic, or geographic patterns in school overdoses.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.